CureSureMedico
|
EN

Stem Cell Therapy

Hematology

payments

Starting from

$3,000

Up to $80,000 depending on centre

schedule

Typical duration

14–60 days

Including pre-operative work-up

arrow_downwardlocal_hospital

Partner hospitals

22

Vetted for outcome data & accreditation

Overview

Therapeutic use of stem cells — haematopoietic, mesenchymal, or induced pluripotent — to repair, regenerate, or replace damaged tissue in blood disorders, degenerative conditions, and select autoimmune diseases.

Your case is matched to a centre on the basis of clinical outcome data, not marketing. We coordinate every step — from pre-operative work-up to post-treatment follow-up — with a dedicated care coordinator.

What's included

Pre-treatment evaluation & disease staging
Stem cell collection or donor sourcing
Laboratory processing & quality verification
Infusion / transplant procedure
Post-treatment monitoring & engraftment assessment
Haematologist & clinical team fees
Interpreter & care coordinator
Long-term follow-up plan at home

Stem Cell Therapy

Coordinated from

$3,000

or message us on WhatsApp

No commitment required. Your data is never shared with third parties.

Global cost comparison — Stem Cell Therapy

Average coordinated costs across our partner centres. Final pricing depends on clinical complexity and chosen hospital.

CountryAvg. costvs. cheapest
🇮🇳

India

New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi

Best value
$4,600
chevron_right
🇹🇷

Turkey

Istanbul

$20,000
chevron_right
🇹🇭

Thailand

Bangkok · Phuket · Chiang Mai

$25,000
chevron_right

Costs are indicative and reviewed quarterly. Request a personalised estimate for your specific case.

Partner hospitals

22 centres
View all hospitals
Amrita Hospital

Amrita Hospital

Faridabad, India

Asia's largest private hospital — 2,600 beds, 64 operation theatres, 81 specialties on a 130-acre campus in Delhi NCR. NABH & NABL accredited. Centres of excellence in oncology, cardiac surgery, BMT, organ transplantation, neurosciences, and IVF.

NABHNABL

800+

Specialists

2,600+

Beds

View Profile
Cytecare Cancer Hospitals

Cytecare Cancer Hospitals

Bengaluru, India

India's first purpose-built organ-specific oncology hospital. Ranked #1 in Bengaluru and #7 in India (Outlook Health 2025). JCI, NABH & ESMO accredited — surgical, medical and radiation oncology with dedicated BMT unit and Elekta Versa HD linac.

NABHNABLESMO Designated Centre

64+

Specialists

150+

Beds

View Profile
Medanta – The Medicity

Medanta – The Medicity

Gurugram, India

Medanta – The Medicity is India's #1 hospital (Newsweek World's Best Hospitals 2026), founded by renowned cardiovascular surgeon Dr. Naresh Trehan on a 43-acre campus in Sector 38, Gurugram. The flagship facility operates 1,391 beds including 270+ ICU beds, 40 operating theatres, and 900+ experienced physicians across 30+ specialties. Medanta is the only Indian private hospital to be consistently ranked among the world's top 150 medical facilities, and receives over 20,000 international patients annually from more than 130 countries. Its centres of excellence span cardiac care, oncology, neurosciences, organ transplantation, gastrosciences, and orthopaedics, backed by JCI, NABH, and NABL accreditation.

JCINABHNABL

900+

Specialists

1,391+

Beds

View Profile
Fortis Memorial Research Institute

Fortis Memorial Research Institute

Gurugram, India

Fortis Memorial Research Institute (FMRI) in Sector 44, Gurugram is one of India's most advanced tertiary care hospitals, offering 1,000+ beds across 40+ specialties. Home to leading specialists in neurosurgery, cardiac surgery, oncology, organ transplantation, and orthopaedics, FMRI features CyberKnife radiosurgery, CAR-T cell therapy, and full robotic surgery capabilities. The hospital serves patients from 118 countries, supported by a dedicated international patients department providing visa assistance, interpreters, airport transfers, and end-to-end care coordination.

JCINABHNABL

400+

Specialists

330+

Beds

View Profile

Frequently asked questions

Established indications include blood cancers (leukaemia, lymphoma, myeloma), bone marrow failure, sickle cell disease, and thalassaemia via HSCT. Mesenchymal stem cell therapy is used for select autoimmune and orthopaedic conditions. CAR T-cell therapy targets certain relapsed or refractory blood cancers.

No fees. No commitment.

Our guidance is completely free

We are compensated by our partner hospitals — never by patients. You get independent clinical matching, cost transparency, and end-to-end coordination at no cost to you.

Message us on WhatsApp